Bespak in talks with potential acquirer:
This article was originally published in Clinica
Executive Summary
UK drug delivery device manufacturer Bespak today revealed it is in "very preliminary" discussions with an unnamed party over a potential takeover bid for the company. The news gave a boost to the UK firm's shares, which have taken a tumble over recent months following disappointing sales of its Exubera insulin inhaler (see Clinica No 1265, p 13). Nomura Code analyst Charles Weston suggested that Bespak's potential suitors could include other medical device plastics manufacturer, who could generate significant cost synergies, or leveraged buy-out firms, who could use the company's strong free cash flow generation to "heavily gear the balance sheet".